BioCardia Inc.
NASDAQ:BCDA
| Market Cap (Intraday) | 9.24M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.38 |
| 50-Day MA | $0.42 |
| 200-Day MA | $0.67 |
BioCardia Inc. Stock, NASDAQ:BCDA
320 Soquel Way, Suite B, Sunnyvale, California 94085
United States of America
Phone: +1.650.226.0120
Number of Employees: 20
Description
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.